Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001873392-26-000004

President & COO sold 15,000 shares at $15.33 ($229,953)

  • President & COO acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dowden Nathan J President & COO 2026-05-04 Option exercise 10b5-1 +15,000 $1.74 $26,100 213,588 D
Dowden Nathan J President & COO 2026-05-04 Sale 10b5-1 −15,000 $15.33 $229,953 198,588 D
Derivatives
Dowden Nathan J President & COO 2026-05-04 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 49,831 D
Open-market sales · 15,000 sh · avg $15.33 · $229,953
Loading xslF345X06/wk-form4_1777937054.xml…